Cite
HARVARD Citation
Calza, L. et al. (2019). Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. Infectious diseases. 51 (8), pp. 593-601. [Online].